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Despite advances in the medical field, bronchopulmonary dysplasia (BPD) 
remains a major concern for preterm infants. A hallmark characteristic of BPD is 
impaired alveolar formation. Contributing to impaired alveolar formation and the 
development of BPD is respiratory support as well as poor postnatal growth and 
inadequate nutrition. The contribution of respiratory support has been well characterized 
in the development of BPD; however, the role that postnatal growth restriction (PGR) 
plays in impaired alveolar formation and the development of BPD is less understood.  
Our study focused on determining the downstream molecular mediators of altered 
essential long-chain fatty acids in alveolar formation, peroxisome proliferator activated 
receptor gamma (PPARγ), and fatty acid binding protein 4 (FABP4). We hypothesize 
that PGR decreases circulating essential fatty acids in the rat, in association with 
increased lung mRNA and protein levels of FABP4, and reduced levels of lung PPARγ 
protein. 
To test this hypothesis, PGR was induced in our rat model using variation in litter 
size by cross-fostering newborn rat pups into rat dams with litter sizes of 16 (PGR) or 8 
(control).  Rat pup weights were measured every other day from birth to day of life 21 
(d21). GC-MS was used to measure serum and lung fatty acid profiles at d21. RT-PCR 
was used to measure PPARγ, and FABP4 mRNA abundance in the lung at d21. Western 
 iv 
blotting was used to measure PPARγ, and FABP4 protein abundance in the lung at d21.  
PGR reduced serum LA, AA, ALA, and DHA in male rat pups compared to sex-
matched controls. PGR significantly decreased PPARγ protein abundance in male rat 
pups compared to sex-matched controls. PGR also increased FABP4 mRNA, and FABP4 
protein abundance in male rat pups compared to sex-matched controls.  
We conclude that PGR alters serum fatty acid profiles, as well as PPARγ, and 
FABP4 levels in a sex-divergent manner. The effects that PGR has on serum fatty acid 
profiles, PPARγ, and FABP4 may have a potential impact on the development of BPD. 
We speculate that PGR causes alterations in serum fatty acids, which inhibit nutrient 
responsive signaling pathways that are vital for alveolar formation.  
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Bronchopulmonary Dysplasia (BPD) is a serious and common consequence of 
preterm birth. BPD, the chronic lung disease of early infancy, affects 10,000 preterm 
infants (<37 weeks gestation) each year in the United States.1 BPD results in high 
morbidity and mortality in the neonatal period, and predisposes survivors to long-term 
deficits in lung health. Male infants are more severely affected than female infants, with 
increased risk and severity of BPD.2,3 A key feature of BPD is impaired alveolar 
formation. 
Impaired alveolar formation in the context of BPD occurs in part because, in the 
human lung, alveolar formation begins before term birth, at approximately 28-32 weeks 
gestation. Preterm infants being cared for in the neonatal intensive care setting frequently 
receive respiratory support secondary to immature lungs. Prolonged, invasive mechanical 
ventilation with oxygen rich gas is well established to contribute to the development of 
BPD. Another contributor to the development of BPD and impaired alveolar formation is 
poor postnatal growth and inadequate nutrition.4,5,6 
 Inadequate postnatal growth and nutrition often accompany preterm birth, and 
lead to postnatal growth restriction (PGR).7 In preterm infants, PGR results from severe 





During development, adequate nutrition is vital to supplying appropriate nutrients 
for activation of nutrient responsive signaling pathways. Evidence for the importance of 
nutrition on alveolar integrity is provided through animal models. We previously 
demonstrated, in a preterm lamb model of evolving BPD, that impaired nutrition in the 
postnatal period contributed to impaired alveolar formation.4 We also showed that in a rat 
model, prenatal growth restriction impaired alveolar formation.8,9  Other studies that 
support the role of nutrition in alveolar integrity include calorically restricted adult mice 
that have suppression of cell replication in the lung and alveolar destruction.10,11 
Importantly, refeeding the calorically restricted adult mice with an ad libitum diet 
stimulates cell replication gene expression and alveolar regeneration.10,11 Collectively, 
these findings suggest that alveolar simplification in BPD may be a result from 
inadequate nutrition, or deficiencies in specific macronutrients that are important for the 
activation of nutrient responsive signaling pathways.  
One macronutrient important in alveolar formation and BPD is the essential long 
chain fatty acid. Essential fatty acids are not only good energy sources; they also regulate 
nutrient responsive signaling pathways and moderate inflammation. Linoleic Acid (LA) 
is an essential omega 6 fatty acid (ω6), and a precursor molecule for Arachidonic Acid 
(AA). ω6 fatty acids, particularly AA, play an important role in phospholipid structure, 
cell division, and signaling.12 Though adequate amounts of AA are important for infant 
growth, excessive levels of LA are associated with inflammation in preterm lung 
development. Also important for infant growth and alveolar formation are the essential 
omega-3 (ω3) long chain fatty acids, α-linoleic acid (ALA), and its derivative 





Preterm infants who develop BPD have altered circulating essential fatty acid 
profiles characterized by decreased circulating AA and decreased circulating DHA.  Also 
altered in preterm infants who develop BPD is the ratio of LA to DHA, which is 
increased.13 During the last trimester of pregnancy, the placenta facilitates an increased 
transfer of AA and DHA, while limiting the transfer of LA. When the last trimester of 
pregnancy is disrupted by preterm birth, AA and DHA levels become limited. Preterm 
infants must rely on external sources for essential fatty acids, thus LA, the primary lipid 
used in neonatal intensive care feeding practices, become excessive.  
An essential fatty acid that has been extensively studied in the context of the lung 
is DHA. Shown to reduce inflammation in lung development of preterm infants, DHA is 
also a peroxisome proliferator activated receptor gamma (PPARγ) agonist.3,14,15 Lung 
development depends on nutrient activation of the transcriptional regulator PPARγ, in 
part, by DHA.  
PPARγ, a member of the PPAR subfamily of nuclear receptors, is critical for lung 
development. PPARγ signaling is nutrient responsive, and inadequate nutrition can lead 
to alveolar simplification via PPARγ signaling.8 One important ligand for PPARγ is 
DHA, which has a higher affinity for PPARγ than other long chain fatty acids.16 Ligand 
activation of PPARγ by DHA results in the transcription of downstream PPARγ target 
genes that facilitate alveolar formation. However, in order for DHA to interact with 
PPARγ, DHA must be transported into the nucleus via a fatty acid binding protein. 
Fatty Acid Binding Proteins (FABP) is a large family of lipid binding proteins. 




recently has been detected in the lung parenchyma and in alveolar macrophages.15 
FABP4 is thought to regulate the PPARγ pathway.15 FABP4 is a fatty acid chaperone, 
with a high affinity for long chain fatty acids.17,18 FABP4 facilitates the transport of non-
esterified fatty acids from lipid droplets to the nucleus. The fatty acids brought into the 
nucleus via FABP4 subsequently enhance PPARγ transcriptional activity.17–19 The 
trafficking of long chain essential fatty acids into the nucleus is imperative for activation 
of PPARγ and alveolar formation.19  
The interaction between FABP4 and PPARγ extends beyond shuttling of lipids 
into the nucleus. The FABP4 gene is a transcriptional target of PPARγ, and the FABP4 
protein stimulates degradation of PPARγ by the 20S proteasome. In a negative feedback 
loop, PPARγ induces FABP4 mRNA expression. As FABP4 protein accumulates, it 
accelerates PPARγ degradation.20  
Previous studies demonstrate that the combination of respiratory support and PGR 
affect lung development, particularly alveolar formation.4 However, the isolated 
contribution of PGR to alveolar formation has not been examined. To understand the 
isolated contribution of postnatal nutrition to alveolar formation, we optimized a 
previously developed rat model of PGR. We showed that lungs of PGR rat pups differ 
from control in terms of both alveolar formation and lung function, with sex-divergent 
outcomes. Specifically, we showed that in female rat lungs, PGR resulted in thicker 
alveolar walls, but with increases in indices of lung maturation (secondary septa 
formation and radial alveolar count). In contrast, in male rat lung, PGR again resulted in 
increased alveolar wall thickness, but without a change in indices of lung maturation. 




demonstrated that PGR decreased lung compliance in both female and male rat pups, and 
increased lung resistance, with greater effects in male rat lungs.  
However, the effect of PGR on essential fatty acids, PPARγ, and FABP4 in the rat 
lung is unknown. We hypothesize that PGR decreases circulating essential fatty acids in 
the rat, in association with increased lung mRNA and protein levels of FABP4, and 














PGR was induced in Sprague Dawley rat pups using variation in litter size.21 
Newborn rat pups were cross-fostered to rat dams with litter sizes of 16 (PGR) or 8 
(control), with equal numbers of female and male pups in each litter. Rat pup weight was 
measured every other day from birth to postnatal day 21 (d21). At d21, control and PGR 
rat offspring underwent euthanasia using a sodium pentobarbital overdose, and serum and 
lung tissue were collected and immediately flash frozen in liquid nitrogen. In this study, 
we examined 4 groups: PGR females, PGR males, control females, and control males. 




Gas Chromatography- Mass Spectrometry (GC-MS) 
Serum and lung LA, AA, ALA, and DHA were quantified using GC-MS at the 
University of Utah Core facility. Frozen serum was transferred to the University of Utah 
Core facility to quantify relative amounts of fatty acids. Supelco’s FAMES 37 component 
mixture was used as a reference standard. Serum fatty acids are expressed in ng/µL 
serum. For lung fatty acids, a volume of 1 mL of 3% HCl in MeOH containing Supelco’s 
FAMES 37 was added to lung tissue samples. Lung samples were homogenized and 
centrifuged at 15,000 G for 10 minutes at 4 °C. Lung fatty acids are expressed in ng/mg 









Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to 
quantify levels of two PPARγ mRNA variants, PPARγ1 and PPARγ2, as well as FABP4 
mRNA in lungs of rat pups (PGR and control). RNAeasy Mini Kit (Qiagen) was used to 
extract RNA from lung tissue samples. To generate cDNA, a High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems) was used. The following Assay-on 
demand primer/probe sets were used: PPARγ1 – Rn01492274_m1, PPARγ2 – 
Rn00440940_m1, FABP4 – Rn00670361_m1. GAPDH was used as an internal control. 
GAPDH primer and probe sequences; Forward: CAAGATGGTGAAGGTCGGTGT; 
Reverse: CAAGAGAAGGCAGCCCTGGT; Probe: 
GCGTCCGATACGGCCAAATCCG. QuantiStudio 12K Flex Real Time PCR system 
was used for RT-PCR amplification at the University of Utah Genomics Core Facility 






Western blots were used to quantify protein abundance of PPARγ, and FABP4 in 
the rat lung. Rat lung tissue was crushed using a mortar and pestle with liquid nitrogen. A 
RIPA buffer and protein inhibitor mixture (Roche-Complete Mini) was used to isolate 




protein abundance. Protein samples were stored at -80° C until use. A total of 10 µg of 
protein homogenate was loaded on a 10% Bis-Tris Polyacrylamid Midi Gels (Novex by 
Life Technologies) to analyze PPARγ protein abundance. A total of 15 µg of protein 
homogenate was loaded on a 4-12% Bis-Tris Polyacrylamide Midi Gels (Novex by Life 
Technologies) to analyze FABP4 protein abundance. The following primary antibodies 
were used: PPARγ (H-100, Santa Cruz Biotechnology), FABP4 (12802-1-AP, 
ProteinTech), FABP4 (RP1085, Boster), and GAPDH (14C10, Cell Signaling 
Technology). All antibodies were identified with Western Lighting enhanced 





Female and male rats were considered separate groups. Data are presented as 
mean + standard deviation, for a sample size of n= 6-10 per group. Non-parametric tests 
were used to detect statistically significant differences. For comparisons between all 
groups, ANOVA with Fisher’s Least-Significant-Difference test was used. For pair-wise 
comparisons, Mann-Whitney U test was used. Analysis was performed using the 















PGR and Control Body Weights 
 
PGR affects both female and male rat pups. PGR female rat pups weigh 
significantly less than their sex-matched control by postnatal d5 and continue to weigh 
significantly less through postnatal d21 (Figure 1A). Similarly, PGR male rat pups weigh 
significantly less than their sex-matched control by postnatal d5 and continue to weigh 




Serum and Lung Fatty Acid Levels  
In order to understand the effects of PGR on fatty acid levels in the serum and in 
the lung, we quantified LA, AA, ALA, and DHA, as well as LA:DHA ratios in female 
and male, Control, and PGR rat pups. We also assessed whether there was a baseline sex-
difference in serum or lung fatty acid levels in the control rats.  
For LA, levels were similar between control female and control male rat pups in 
both the serum and the lung. In serum, PGR increased LA levels in female rat pups 
compared to female controls (p < 0.05, n = 6) (Figure 2A). In contrast, PGR decreased 
LA levels in male rat pups compared to male controls  (p < 0.01, n = 6) (Figure 2A). In 
lung, PGR did not affect LA levels in female or male groups (Figure 2B). 




female rat pups (p < 0.01, n = 6); however, lung AA levels were similar between male 
and female rats. In serum, PGR increased serum AA in female rat pups compared to 
female controls (p < 0.05, n = 6) (Figure 3A). Again, in contrast, PGR decreased AA in 
male rat pups compared to male controls (p < 0.01, n = 6) (Figure 3A). In lung, PGR did 
not affect lung AA in female or male rat pups (Figure 3B). 
For ALA, levels were similar between control female and control male rat pups in 
both the serum and the lung (Figure 4A). In serum, PGR did not affect ALA levels in 
females (Figure 4A). However, PGR decreased ALA in male serum compared to male 
controls (p < 0.05, n = 6) (Figure 4A). In lung, PGR did not affect ALA levels in female 
or male rat pups (Figure 4B). 
For DHA, control male rat pups had significantly higher serum DHA than control 
female rat pups (p < 0.05, n = 6) (Figure 5A), while male rat pups had lower lung DHA 
than female rat pups (p < 0.05, n = 6) (Figure 5B). In serum, PGR did not affect DHA 
levels in female rat pups. In contrast, PGR decreased serum DHA in male rat pups 
compared to male controls (p < 0.01, n = 6)(Figure 5A). In lung, PGR decreased DHA 
levels in female rat pups compared to female controls (p < 0.01, n = 6). In contrast, PGR 
did not affect lung DHA in male rat pups (Figure 5B).  
For LA:DHA ratios, levels were similar between female control and male control 
rat pups both in the serum and in the lung. In serum, PGR did not affect LA:DHA ratios 
in female rat pups. However, PGR significantly increased LA:DHA ratios in male rat 
pups compared to controls (p < 0.05, n = 6) (Figure 6A). In lung, PGR did not affect 





PPARγ and FABP4 mRNA Levels 
PPARγ1 and PPARγ2 mRNA transcript levels were not different between control 
female and control male rat lung (Figure 7A). Similarly, PGR did not alter lung levels of 
PPARγ1, or PPARγ2 mRNA transcript in female or male rat pups (Figure 7A, 7B).  
FABP4 mRNA transcript levels were also not different between control female 
and control male rat lung (Figure 8). PGR did not alter lung levels of FABP4 mRNA 
transcript in females compared to female control (Figure 8). In contrast, PGR increased 
FABP4 mRNA transcript levels in male rat lung compared to male control (p < 0.01, n = 




PPARγ and FABP4 Protein Abundance 
PPARγ protein abundance is higher in control male rat lung than in control female 
rat lung (p < 0.01, n = 6) (Figure 9). FABP4 protein abundance was not different between 
female control and male control rat lung (Figure 10A, Figure 10B). PGR did not alter 
PPARγ protein abundance in female rat lung compared to female control. However, PGR 
decreased PPARγ protein abundance in male rat lung compared to male control (p < 0.01, 
n = 6) (Figure 9). Similarly, PGR did not affect FABP4 protein abundance in female rat 
pups compared to female control (Figure 10A). However, PGR significantly increased 
FABP4 protein abundance in male rat pups compared to male control (p ≤ 0.05, n = 6) 








Figure 1 Growth Trajectory of Female and Male, Control and PGR Rat Pups: (A) Weight 
of female control and PGR rat pups, and (B) weight of male control and PGR rat pups. 
PGR female and male body weight is significantly less than sex-matched control by 







Figure 2 Serum and Lung LA Levels: (A) ng LA/ µL serum in female and male, control 
and PGR rat pups and, (B) ng LA/mg tissue in female and male control and PGR rat 
pups. PGR significantly increases serum LA in PGR females and significantly decreases 
















Figure 3 Serum and Lung AA Levels: (A) ng AA/ µL serum in female and male, control 
and PGR rat pups, and (B) ng AA/mg tissue in female and male control and PGR rat 
pups. Male controls have increased serum AA compared to female controls. PGR 
increases serum AA in females, and decreases AA in males. No significant changes were 






























Figure 4 Serum and Lung ALA Levels: (A) ng ALA/ µL serum in female and male, 
control and PGR rat pups and, (B) ng ALA/mg tissue in female and male control and 
PGR rat pups. Male controls have no change in serum ALA compared to female controls. 
PGR has no effect on female rat pups compared to sex-matched control, but decreases 


























Figure 5 Serum and Lung DHA Levels: (A) ng DHA/ µL serum in female and male, 
control and PGR rat pups, and (B) ng DHA/mg tissue in female and male control and 
PGR rat pups. Male controls have significantly higher DHA compared to female controls. 
PGR decreases serum DHA in males, but has no affect on females. In lung, male controls 
have significantly lower lung DHA compared to female controls. PGR decreases lung 































Figure 6 Serum and Lung LA:DHA Ratios: (A) ng LA:DHA/ µL serum in female and 
male, control and PGR rat pups, and (B) ng LA:DHA/mg tissue in female and male 
control and PGR rat pups. PGR increases serum LA:DHA in males, but has no effect on 











Figure 7 PPARγ1 and PPARγ2 mRNA Transcript Levels: PGR had no effect on (A) 







Figure 8 FABP4 mRNA Transcript Levels: PGR had no effect on FABP4 mRNA 
transcript levels in female rat pups. PGR significantly increased FABP4 mRNA transcript 















Figure 9 PPARγ Protein Abundance: Male controls have significantly higher PPARγ 
protein abundance compared to female controls. PGR decreases PPARγ protein 























Figure 10 FABP4 Protein Abundance: PGR has no effect on (A) FABP4 protein 
abundance in female rat pups. PGR significantly increases (B) FABP4 protein abundance 

















In our study, we demonstrated that, in the rat, PGR causes sex-divergent changes 
in serum fatty acids, as well as lung expression of PPARγ and FABP4. Combined with 
our previous data showing sex-divergent alterations in alveolar formation, and lung 
function in PGR rat pups, these data suggest that altered fatty acid signaling may 
contribute to sex-divergent lung outcomes. PGR-induced changes to fatty acid signaling 
may be manipulated with dietary fatty acid supplementation. Therefore, these data will 
inform subsequent studies aimed at developing a targeted fatty acid-based intervention to 
improve lung outcomes in PGR.  
In our study, PGR significantly decreased serum levels of LA, AA, ALA, and 
DHA, but only in male rat pups, with minimal effects in female rat pups. In addition, the 
ratio of LA:DHA was increased in male, but not female, rat pups. Similar findings were 
observed in a study by Martin et al., in which preterm infants who developed BPD had a 
fatty acid profile of decreased AA, DHA, and increased LA: DHA ratio.13 These 
alterations in serum fatty acid profiles have two important implications. First, the profile 
observed in our male rat pups suggests that PGR may have an impact on alveolar 
formation by inhibiting the activation of nutrient signaling pathways. Potentially, a 
similar mechanism contributes to poor lung outcomes in human preterm infants, who also 




not related to intake, as both female and male rat pups received rat milk from the same rat 
dams. Therefore, sex-specific fatty acid profiles may be the result of sex-specific fatty 
acid metabolism within the liver.23 In a study by Ryan et al., in which preterm infants 
were randomly assigned to a control formula or a formula supplemented with DHA, 
preterm male infants, but not preterm female infants, had a significant negative effect on 
growth and body composition.24 These results in combination with other studies imply 
that sex hormones may influence fatty acid metabolism through the enzymatic synthesis 
of long chain fatty acids. Another possible contributing factor to sex-specific differences 
in fatty acid uptake is different tissues, including adipose tissue.25 Preterm infants are 
more prone to develop increased adipose tissue, especially intra-abdominal adiposity, as 
compared to term-born infants.26 In a study by Thomas et al., ex-preterm, adult men were 
susceptible to accumulating excess internal adipose tissue, specifically in the abdominal 
area.27 Lack of change in fatty acid profiles within non-phospholipid space within the 
lung, however, suggest that this particular compartment is not contributing to 
sequestering of lipids in a sex-divergent manner.  
Historically, serum fatty acid levels have been used as biomarkers for lung 
diseases including lung cancer, chronic lung disease, and BPD.13,28 Our observations are 
consistent with the use of serum fatty acid profiles as a marker of lung outcomes, despite 
these profiles not reflecting lung fatty acid profiles.  
The involvement of PPARγ signaling in lung developmental outcomes is well 
established. Required for lung development and lung vascular integrity, PPARγ is 
necessary for epithelial-mesenchymal interactions.29–31 Altered lung development, along 




Additionally, prenatal restricted rat pups have demonstrated impaired alveolar formation, 
decreased PPARγ, and altered lung function compared to non-growth-restricted rat 
pups.8,9 Consistent with these observations, in our model, PGR reduced PPARγ lung 
protein abundance in male rat pups. Given our previous observations of thicker airspace 
walls and altered lung mechanics in male rats following PGR, we speculate that 
decreased PPARγ may be contributing to lung outcomes in male rats, potentially by 
reducing expression of target genes critical for lung development.30  
Our study also provides novel insight into potential mechanisms by which PPARγ 
protein may be reduced in the lung of male PGR rat pups. Previous studies demonstrated 
a negative feedback loop between FABP4 and PPARγ, in which FABP4 negatively 
regulates PPARγ.20 The authors of this study demonstrated that FABP4 accelerates 
proteasomal degradation of PPARγ.20 Our findings of increased FABP4 protein 
abundance in PGR male rat pups, in the context of reduced PPARγ, are consistent with 
this mechanism. Ghelfi et al. showed in their baboon model of BPD increased levels of 
FABP4 mRNA transcript levels and increased FABP4 protein abundance in BPD tissues 
compared to their controls.15 FABP4 was also detected in human lung samples of BPD in 
the same study. Ongoing studies are evaluating PPARγ ubiquitination and targeting to the 
proteasome in PGR rat lungs.   
An important part of the negative feedback loop between PPARγ and FABP4 is 
the regulation of FABP4 transcription by PPARγ.20 Again our data demonstrating 
increased FABP4 mRNA transcript in PGR males, as well as FABP4 protein, support the 
presence of a negative feedback loop involving PPARγ and FABP4.  The mechanism by 




as a fatty acid chaperone with the role of transporting fatty acids into the nucleus to 
activate PPARγ, we speculate that up-regulation of FABP4 may be a compensatory in the 
face of reduced serum essential fatty acids in male rat pups.19,20 
Our study is not without limitations. First, we did not examine the composition of 
the rat milk being produced by control and PGR rat pups. Previous studies do suggest that 
varying rat litter sizes influence milk composition, and therefore nutrient intake of rat 
pups.32 Second, we did not assess the phospholipid compartment in the lung. It is possible 
that sequestering of circulating lipids in male rat lungs occurs at the level of the 
phospholipid membrane.33,34 Ongoing studies are evaluating the fatty acid profile of this 
compartment. Finally, our study is associative and does not confirm a cause-and-effect 
relationship between serum lipids, PPARγ, or FABP4 and lung outcomes. Ongoing 
studies in the lab are supplementing rat dams with diets containing DHA and/or AA in 
the context of PGR to determine if lung outcomes can be improved by restoring lipid 
profiles.  
In conclusion, our study demonstrates that PGR alters serum fatty acid profiles, as 
well as PPARγ, and FABP4 levels, all of which may have a potential impact on alveolar 
formation and the development of BPD. The sex-divergent changes that we observed are 
consistent with previous studies which have found that male infants are more severely 
affected than female infants, with increased risk and severity of BPD.2,3 We speculate 
that PGR-induced alterations in serum fatty acids impede nutrient activated pathways 
vital for alveolar formation. Our results emphasize the important role that postnatal 
nutrition has on a molecular pathway that is integral for alveolar formation and the 
prevention of BPD.
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